Search Results - "Nevill, T J"

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens by Abou-Mourad, Y R, Lau, B C, Barnett, M J, Forrest, D L, Hogge, D E, Nantel, S H, Nevill, T J, Shepherd, J D, Smith, C A, Song, K W, Sutherland, H J, Toze, C L, Lavoie, J C

“…We analyzed the late outcomes of 429 long-term survivors post allogeneic hematopoietic SCT (allo-HSCT) who received transplant in our center between 1981 and…”
Get full text

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes by Song, KW, Barnett, MJ, Gascoyne, RD, Chhanabhai, M, Forrest, DL, Hogge, DE, Lavoie, JC, Nantel, SH, Nevill, TJ, Shepherd, JD, Smith, CA, Sutherland, HJ, Toze, CL, Voss, NJ, Connors, JM

“…Background: Controversy exists regarding the role of high-dose therapy followed by stem-cell transplant (SCT) in the treatment of T-cell lymphoblastic lymphoma…”
Get full text

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease by TOZE, C. L, GALAL, A, VOSS, N. J, KISS, T. L, MESSNER, H. A, LAVOIE, J. C, FORREST, D. L, SONG, K. W, SMITH, C. A, LIPTON, J, BARNETT, M. J, SHEPHERD, J. D, CONNEALLY, E. A, HOGGE, D. E, NANTEL, S. H, NEVILL, T. J, SUTHERLAND, H. J, CONNORS, J. M

“…In all, 30 patients with CLL proceeded to myeloablative allogeneic BMT using related (n=20, 67%) or unrelated (n=10) donors, at the Princess Margaret Hospital…”
Get full text

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia by Greenwood, M. J., Seftel, M. D., Richardson, C., Barbaric, D., Barnett, M. J., Bruyere, H., Forrest, D. L., Horsman, D. E., Smith, C., Song, K., Sutherland, H. J., Toze, C. L., Nevill, T. J., Nantel, S. H., Hogge, D. E.

“…Acute myeloid leukemia (AML) presenting with a high leukocyte count has been associated with an increase in induction mortality and poor results in a number of…”
Get full text

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia by Halim, TY, Song, KW, Barnett, MJ, Forrest, DL, Hogge, DE, Nantel, SH, Nevill, TJ, Shepherd, JD, Smith, CA, Sutherland, HJ, Toze, CL, Lavoie, JC

“…Background: Curative intent chemotherapy for acute myelogenous leukemia (AML) leads to prolonged severe neutropenia, during which patients are highly…”
Get full text

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis by FORREST, D. L, NEVILL, T. J, SUTHERLAND, H. J, TOZE, C. L, DAVIS, J. H, HOGGE, D. E, NAIMAN, S. C, LE, A, BROCKINGTON, D. A, BARNETT, M. J, LAVOIE, J. C, NANTEL, S. H, SONG, K. W, SHEPHERD, J. D

“…To establish incidence and risk factors for development of second malignant neoplasms after high-dose chemo/radiotherapy (HDT) and autologous hematopoietic…”
Get full text

Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study by Seftel, M D, Paulson, K, Doocey, R, Song, K, Czaykowski, P, Coppin, C, Forrest, D, Hogge, D, Kollmansberger, C, Smith, C A, Shepherd, J D, Toze, C L, Murray, N, Sutherland, H, Nantel, S, Nevill, T J, Barnett, M J

“…Failure of cisplatin-based chemotherapy in advanced germ cell tumour (GCT) is associated with a poor outcome. High-dose chemotherapy and auto-SCT is one…”
Get full text

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results by Ramadan, K M, Connors, J M, Al-Tourah, A J, Song, K W, Gascoyne, R D, Barnett, M J, Nevill, T J, Shepherd, J D, Nantel, S H, Sutherland, H J, Forrest, D L, Hogge, D E, Lavoie, J C, Abou-Mourad, Y R, Chhanabhai, M, Voss, N J, Brinkman, R R, Smith, C A, Toze, C L

“…Outcome is poor with conventional therapy for relapsed transformed non-Hodgkin's lymphoma (NHL). Autologous SCT has been successfully employed; however the…”
Get full text

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia by TOZE, C. L, SHEPHERD, J. D, RECCE, D. E, SUTHERLAND, H. J, BARNETT, M. J, CONNORS, J. M, VOSS, N. J, GASCOYNE, R. D, HOGGE, D. E, KLINGEMANN, H.-G, NANTEL, S. H, NEVILL, T. J, PHILLIPS, G. L

“…Twenty-six patients with low-grade lymphoma (LGL) (n = 18) or chronic lymphocytic leukemia (CLL) (n = 8) received allogeneic BMTs between 1985 and 1998. Median…”
Get full text

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML by Nevill, T J, Hogge, D E, Toze, C L, Nantel, S H, Power, M M, Abou Mourad, Y R, Song, K W, Lavoie, J C, Forrest, D L, Barnett, M J, Shepherd, J D, Nitta, J Y, Wong, S, Sutherland, H J, Smith, C A

“…Administration of alkylating agents (Alk), topoisomerase II inhibitors (Topo II) and radiotherapy (RT) can result in therapy-related myelodysplastic syndrome…”
Get full text

Lymphoproliferative disorders following allogeneic bone marrow transplantation : the Vancouver experience by MICALLEF, I. N. M, CHHANABHAI, M, NEVILL, T. J, LE, A, BARNETT, M. J, GASCOYNE, R. D, SHEPHERD, J. D, FUNG, H. C, NANTEL, S. H, TOZE, C. L, KLINGEMANN, H.-G, SUTHERLAND, H. J, HOGGE, D. E

“…Between June 1988 and May 1996, 428 patients underwent allogeneic BMT (288 related donor (RD) and 140 unrelated donor (UD)) at the Vancouver General Hospital…”
Get full text

Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation by KURUVILLA, J, FORREST, D. L, LAVOIE, J. C, NANTEL, S. H, SHEPHERD, J. D, SONG, K. W, SUTHERLAND, H. J, TOZE, C. L, HOGGE, D. E, NEVILL, T. J

“…Endocarditis is an uncommon complication of hematopoietic stem cell transplantation (HSCT). A retrospective review of 1547 patients who underwent HSCT in…”
Get full text

Note: Characterization of electrode materials for dielectric spectroscopy by Malleo, D, Nevill, J T, van Ooyen, A, Schnakenberg, U, Lee, L P, Morgan, H

“…When measuring the dielectric properties of aqueous samples, the impedance of the electrode/sample interface can limit low frequency measurements. The…”
Get more information

High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation by SIMPSON, D. R, NEVILL, T. J, KLINGEMANN, H. G, NAIMAN, S. C, BARNETT, M. J, SHEPHERD, J. D, FUNG, H. C, HORSMAN, D. E, NANTEL, S. H, VICKARS, L. M, SUTHERLAND, H. J, TOZE, C. L, HOGGE, D. E

“…While allogeneic stem cell transplantation (SCT) is curative for a significant number of patients with AML, relapse of disease within the bone marrow and/or…”
Get full text

Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation by SCHULTZ, K. R, NEVILL, T. J, BALSHAW, R. F, TOZE, C. L, CORR, T, CURRIE, C. J, STRONG, D. K, KEOWN, P. A

“…Cyclosporin A (CsA) absorption is highly variable in BMT patients. Neoral, a new microemulsion formulation of CsA, permits increased absorption with less…”
Get full text

Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma by Forrest, D L, Thompson, K, Nevill, T J, Couban, S, Fernandez, L A V

“…Between 1993 and 2000, 24 patients with follicular lymphoma underwent high-dose chemo/radiotherapy and allogeneic hematopoietic stem cell transplantation…”
Get full text

Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22) by Seftel, M.D., Bruyere, H., Copland, M., Hogge, D.E., Horsman, D.E., Nantel, S.H., Shepherd, J.D., Lavoie, J.C., Le, A., Sutherland, H.J., Toze, C.L., Nevill, T.J.

“…: Tumour lysis syndrome (TLS) is caused by rapid breakdown of malignant cells resulting in electrolyte disturbances and acute renal failure. TLS has rarely…”
Get full text

Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation by Nevill, T J, Barnett, M J, Klingemann, H G, Reece, D E, Shepherd, J D, Phillips, G L

“…The regimen-related toxicity (RRT) of a busulfan (16 mg/kg) and cyclophosphamide (120 mg/kg) conditioning regimen (BuCy) was evaluated in 70 consecutive…”
Get more information

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease by REECE, D. E, NEVILL, T. J, SUTHERLAND, H. J, VOSS, N. J. S, FAIREY, R. N, O'REILLY, S. E, PHILLIPS, G. L, SAYEGH, A, SPINELLI, J. J, BROCKINGTON, D. A, BARNETT, M. J, KLINGEMANN, H.-G, CONNORS, J. M, NANTEL, S. H, SHEPHERD, J. D

“…This analysis compares the regimen-related toxicity (RRT) and overall non-relapse mortality (NRM) in Hodgkin's disease patients conditioned with either CBV…”
Get full text

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes by McGraw, K L, Zhang, L M, Rollison, D E, Basiorka, A A, Fulp, W, Rawal, B, Jerez, A, Billingsley, D L, Lin, H-Y, Kurtin, S E, Yoder, S, Zhang, Y, Guinta, K, Mallo, M, Solé, F, Calasanz, M J, Cervera, J, Such, E, González, T, Nevill, T J, Haferlach, T, Smith, A E, Kulasekararaj, A, Mufti, G, Karsan, A, Maciejewski, J P, Sokol, L, Epling-Burnette, P K, Wei, S, List, A F

“…Nonsynonymous TP53 exon 4 single-nucleotide polymorphism (SNP), R72P, is linked to cancer and mutagen susceptibility. R72P associations with specific cancer…”
Get full text